Surgery Partners Reaffirms 2026 Guidance, Announces Idaho Falls Sale

EarningsCorporate Action
โดย The Motley Fool·US·Read original
Summary · why it matters

Surgery Partners reported second quarter 2026 results ahead of expectations and reaffirmed its full year guidance while announcing a significant portfolio optimization milestone. Net revenue was approximately $849 million, up 2.7% year-over-year, and adjusted EBITDA was approximately $125 million, with an adjusted EBITDA margin of 14.7%. The company has signed definitive agreements to sell its interest in the Idaho Falls market, including Mountain View Hospital and Idaho Falls Community Hospital, to Intermountain Health for approximately $795 million in gross proceeds, which will be used primarily to pay down debt and reduce balance sheet leverage by approximately 0.3 turns. Excluding the Idaho Falls facilities, second quarter revenue would have been approximately $660 million and adjusted EBITDA approximately $98 million, while first half 2026 revenue would have been roughly $1.29 billion and adjusted EBITDA approximately $173 million. Surgery Partners reaffirmed its full year 2026 guidance of revenue between $3.35 billion and $3.45 billion and adjusted EBITDA of at least $530 million, excluding any financial impact from the pending transaction.

Impact on stocks 2

Health Care · 1 stocks
Surgery Partners Inc
SGRY
▲ PositiveCapitalrelevance

Reaffirmed 2026 guidance and announced sale of Idaho Falls assets for $795M to reduce debt.

Artificial Intelligence · 1 stocks

Off-coverage companies 1

Intermountain HealthPrivate▲ Positive
Capitalrelevance

Acquiring Idaho Falls hospitals from Surgery Partners for $795M, expanding its network.